561 related articles for article (PubMed ID: 28949952)
41. Neural induction with neurogenin1 increases the therapeutic effects of mesenchymal stem cells in the ischemic brain.
Kim SS; Yoo SW; Park TS; Ahn SC; Jeong HS; Kim JW; Chang DY; Cho KG; Kim SU; Huh Y; Lee JE; Lee SY; Lee YD; Suh-Kim H
Stem Cells; 2008 Sep; 26(9):2217-28. PubMed ID: 18617687
[TBL] [Abstract][Full Text] [Related]
42. Retinoic acid-pretreated Wharton's jelly mesenchymal stem cells in combination with triiodothyronine improve expression of neurotrophic factors in the subventricular zone of the rat ischemic brain injury.
Sabbaghziarani F; Mortezaee K; Akbari M; Kashani IR; Soleimani M; Moini A; Ataeinejad N; Zendedel A; Hassanzadeh G
Metab Brain Dis; 2017 Feb; 32(1):185-193. PubMed ID: 27549229
[TBL] [Abstract][Full Text] [Related]
43. Bone Marrow Stromal Cells Combined With Sodium Ferulate and
Zhang Q; Chen ZW; Zhao YH; Liu BW; Liu NW; Ke CC; Tan HM
Cell Transplant; 2017 Feb; 26(2):229-242. PubMed ID: 27772541
[TBL] [Abstract][Full Text] [Related]
44. Interaction between hypothermia and delayed mesenchymal stem cell therapy in neonatal hypoxic-ischemic brain injury.
Herz J; Köster C; Reinboth BS; Dzietko M; Hansen W; Sabir H; van Velthoven C; Bendix I; Felderhoff-Müser U
Brain Behav Immun; 2018 May; 70():118-130. PubMed ID: 29454023
[TBL] [Abstract][Full Text] [Related]
45. Mesenchymal stem cell-based treatments for stroke, neural trauma, and heat stroke.
Hsuan YC; Lin CH; Chang CP; Lin MT
Brain Behav; 2016 Oct; 6(10):e00526. PubMed ID: 27781140
[TBL] [Abstract][Full Text] [Related]
46. Feasibility and safety of intranasally administered mesenchymal stromal cells after perinatal arterial ischaemic stroke in the Netherlands (PASSIoN): a first-in-human, open-label intervention study.
Baak LM; Wagenaar N; van der Aa NE; Groenendaal F; Dudink J; Tataranno ML; Mahamuud U; Verhage CH; Eijsermans RMJC; Smit LS; Jellema RK; de Haan TR; Ter Horst HJ; de Boode WP; Steggerda SJ; Prins HJ; de Haar CG; de Vries LS; van Bel F; Heijnen CJ; Nijboer CH; Benders MJNL
Lancet Neurol; 2022 Jun; 21(6):528-536. PubMed ID: 35568047
[TBL] [Abstract][Full Text] [Related]
47. Recapitulation of in vivo-like paracrine signals of human mesenchymal stem cells for functional neuronal differentiation of human neural stem cells in a 3D microfluidic system.
Yang K; Park HJ; Han S; Lee J; Ko E; Kim J; Lee JS; Yu JH; Song KY; Cheong E; Cho SR; Chung S; Cho SW
Biomaterials; 2015 Sep; 63():177-88. PubMed ID: 26113074
[TBL] [Abstract][Full Text] [Related]
48. Regenerative Potential of the Product "CardioCell" Derived from the Wharton's Jelly Mesenchymal Stem Cells for Treating Hindlimb Ischemia.
Musiał-Wysocka A; Kot M; Sułkowski M; Majka M
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540534
[TBL] [Abstract][Full Text] [Related]
49. Transplantation of neural stem cells overexpressing glial cell line-derived neurotrophic factor enhances Akt and Erk1/2 signaling and neurogenesis in rats after stroke.
Yuan M; Wen SJ; Yang CX; Pang YG; Gao XQ; Liu XQ; Huang L; Yuan QL
Chin Med J (Engl); 2013 Apr; 126(7):1302-9. PubMed ID: 23557563
[TBL] [Abstract][Full Text] [Related]
50. Human Amniotic Fluid Stem Cells: Therapeutic Potential for Perinatal Patients with Intractable Neurological Disease.
Ochiai D; Masuda H; Abe Y; Otani T; Fukutake M; Matsumoto T; Miyakoshi K; Tanaka M
Keio J Med; 2018 Dec; 67(4):57-66. PubMed ID: 29515049
[TBL] [Abstract][Full Text] [Related]
51. Mesenchymal Stem Cells for Ischemic Stroke: Progress and Possibilities.
Maria Ferri AL; Bersano A; Lisini D; Boncoraglio G; Frigerio S; Parati E
Curr Med Chem; 2016 May; 23(16):1598-608. PubMed ID: 26898654
[TBL] [Abstract][Full Text] [Related]
52. The endogenous regenerative capacity of the damaged newborn brain: boosting neurogenesis with mesenchymal stem cell treatment.
Donega V; van Velthoven CT; Nijboer CH; Kavelaars A; Heijnen CJ
J Cereb Blood Flow Metab; 2013 May; 33(5):625-34. PubMed ID: 23403379
[TBL] [Abstract][Full Text] [Related]
53. Transduction of neural precursor cells with TAT-heat shock protein 70 chaperone: therapeutic potential against ischemic stroke after intrastriatal and systemic transplantation.
Doeppner TR; Ewert TA; Tönges L; Herz J; Zechariah A; ElAli A; Ludwig AK; Giebel B; Nagel F; Dietz GP; Weise J; Hermann DM; Bähr M
Stem Cells; 2012 Jun; 30(6):1297-310. PubMed ID: 22593021
[TBL] [Abstract][Full Text] [Related]
54. Intranasal delivery of bone marrow mesenchymal stem cells improved neurovascular regeneration and rescued neuropsychiatric deficits after neonatal stroke in rats.
Wei ZZ; Gu X; Ferdinand A; Lee JH; Ji X; Ji XM; Yu SP; Wei L
Cell Transplant; 2015; 24(3):391-402. PubMed ID: 25647744
[TBL] [Abstract][Full Text] [Related]
55. [Research advances in endogenous neural stem cells promoting neural repair after ischemic stroke].
Fang CY; Wu XS; Zhang H; Gu YL; Wang SB; Ren HW; Chen K; Zhang H; Cheng BH; Gao Y
Sheng Li Xue Bao; 2019 Jun; 71(3):454-462. PubMed ID: 31218336
[TBL] [Abstract][Full Text] [Related]
56. Neurotrophically Induced Mesenchymal Progenitor Cells Derived from Induced Pluripotent Stem Cells Enhance Neuritogenesis via Neurotrophin and Cytokine Production.
Brick RM; Sun AX; Tuan RS
Stem Cells Transl Med; 2018 Jan; 7(1):45-58. PubMed ID: 29215199
[TBL] [Abstract][Full Text] [Related]
57. Protective effects of mesenchymal stem cells on ischemic brain injury: therapeutic perspectives of regenerative medicine.
Bagheri-Mohammadi S
Cell Tissue Bank; 2021 Jun; 22(2):249-262. PubMed ID: 33231840
[TBL] [Abstract][Full Text] [Related]
58. Stem cells in stroke repair: current success and future prospects.
Gopurappilly R; Pal R; Mamidi MK; Dey S; Bhonde R; Das AK
CNS Neurol Disord Drug Targets; 2011 Sep; 10(6):741-56. PubMed ID: 21838668
[TBL] [Abstract][Full Text] [Related]
59. Comparsion between Intravenous Delivered Human Fetal Bone Marrow Mesenchymal Stromal Cells and Mononuclear Cells in the Treatment of Rat Cerebral Infarct.
Huang AH; Zhang PP; Zhang B; Ma BQ; Guan YQ; Zhou YD
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):497-506. PubMed ID: 27825404
[TBL] [Abstract][Full Text] [Related]
60. Strategies to enhance paracrine potency of transplanted mesenchymal stem cells in intractable neonatal disorders.
Park WS; Ahn SY; Sung SI; Ahn JY; Chang YS
Pediatr Res; 2018 Jan; 83(1-2):214-222. PubMed ID: 28972960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
